Future Directions in the Treatment of Mantle Cell Lymphoma
Kami Maddocks, MD, and Alexey Danilov, MD, PhD, close their discussion with a look at the future treatment landscape of mantle cell lymphoma.
Source: onclive.com
Optimizing Bruton Kinase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Optimizing Bruton Kinase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Optimizing Bruton Kinase Today - Breaking & Trending Today
Evaluating Pirtobrutinib in Patients with R/R Mantle Cell Lymphoma
Experts discuss data on pirtobrutinib, a non-covalent BTK inhibitor, in the treatment of patients with relapsed/refractory mantle cell lymphoma.
Source: onclive.com
Data on Covalent BTK Inhibitors for the Treatment of R/R Mantle Cell Lymphoma
Drs Kami Maddocks and Alexey Danilov review data from ongoing studies evaluating covalent BTK inhibitors in relapsed/refractory mantle cell lymphoma.
Source: onclive.com
Bruton Kinase Inhibitors for Relapsed/Refractory Mantle Cell Lymphoma
Kami Maddocks, MD, and Alexey Danilov, MD, PhD, discuss the evolution of BTK inhibitors and how they have changed treatment approaches in clinical practice.
Source: onclive.com
Role of Maintenance Therapy in Newly Diagnosed Mantle Cell Lymphoma
Experts explain the role of maintenance therapy in mantle cell lymphoma and how it impacts the risk of disease progression.
Source: onclive.com